HomeCERS • NASDAQ
add
Cerus Corp
$1.51
Makalipas ang Oras ng Trabaho:(2.65%)+0.040
$1.55
Sarado: Hun 6, 5:42:59 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$1.38
Sakop ng araw
$1.39 - $1.58
Sakop ng taon
$1.12 - $2.54
Market cap
288.65M USD
Average na Volume
1.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 43.24M | 12.70% |
Gastos sa pagpapatakbo | 31.28M | 6.93% |
Net na kita | -7.72M | 20.34% |
Net profit margin | -17.85 | 29.31% |
Kita sa bawat share | -0.04 | 20.00% |
EBITDA | -5.55M | 24.52% |
Aktuwal na % ng binabayarang buwis | -0.97% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 80.92M | 12.11% |
Kabuuang asset | 206.78M | 9.33% |
Kabuuang sagutin | 150.53M | 8.32% |
Kabuuang equity | 56.24M | — |
Natitirang share | 191.16M | — |
Presyo para makapag-book | 4.76 | — |
Return on assets | -7.18% | — |
Return on capital | -9.42% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -7.72M | 20.34% |
Cash mula sa mga operasyon | -844.00K | -143.08% |
Cash mula sa pag-invest | -1.19M | -182.23% |
Cash mula sa financing | 1.07M | -80.74% |
Net change in cash | -776.00K | -108.74% |
Malayang cash flow | -2.15M | -246.13% |
Tungkol
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
Itinatag
Set 1991
Headquarters
Website
Mga Empleyado
622
